Skip to main content

Banque Cantonale Vaudoise

SEC CIK
0001793755
Latest filing
Jul 31, 2026

EW holding history

Edwards Lifesciences Corp in every 13F filed by Banque Cantonale Vaudoise, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EW overviewAll 13F holders of EWFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of EW by Banque Cantonale Vaudoise, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−62,297−100.0%Sold outHolders
Q1 202662,297$4.99M0.2%−4,145−6.2%ReducedHolders
Q4 202566,442$5.66M0.2%−39−0.1%ReducedHolders
Q3 202566,481$5.17M0.2%−185−0.3%ReducedHolders
Q2 202566,666$5.21M0.2%+24,899+59.6%AddedHolders
Q1 202541,767$3.03M0.1%–No prior filingHolders
Q4 2024––––Not filedHolders
Q3 202481,111$5.35M0.2%+25,886+46.9%AddedHolders
Q2 202455,225$5.10M0.2%−2,986−5.1%ReducedHolders
Q1 202458,211$5.56M0.2%−1,724−2.9%ReducedHolders
Q4 202359,935$4.57M0.2%+25,671+74.9%AddedHolders
Q3 202334,264$2.38M0.1%+3,939+13.0%AddedHolders
Q2 202330,325$2.86M0.1%+5,193+20.7%AddedHolders
Q1 202325,132$2.08M0.1%−3,909−13.5%ReducedHolders
Q4 202229,041$2.17M0.1%−2,198−7.0%ReducedHolders
Q3 202231,239$2.58M0.1%−130.0%ReducedHolders
Q2 202231,252$2.97M0.2%−1,136−3.5%ReducedHolders
Q1 202232,388$3.81M0.2%−955−2.9%ReducedHolders
Q4 202133,343$4.32M0.2%−5,787−14.8%ReducedHolders
Q3 202139,130$4.43M0.2%+2,621+7.2%AddedHolders
Q2 202136,509$3.78M0.2%−1,627−4.3%ReducedHolders
Q1 202138,136$3.19M0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.